SHWZ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SHWZ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The historical data trend for Medicine Man Technologies's Cyclically Adjusted Price-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medicine Man Technologies Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Cyclically Adjusted Price-to-FCF | Get a 7-Day Free Trial | - | - | - | - | - |
Medicine Man Technologies Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Cyclically Adjusted Price-to-FCF | Get a 7-Day Free Trial | - | - | - | - | - |
For the Drug Manufacturers - Specialty & Generic subindustry, Medicine Man Technologies's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Medicine Man Technologies's Cyclically Adjusted Price-to-FCF distribution charts can be found below:
* The bar in red indicates where Medicine Man Technologies's Cyclically Adjusted Price-to-FCF falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.
Medicine Man Technologies's Cyclically Adjusted FCF per Share for the fiscal year that ended in Dec23 is calculated as:
For example, Medicine Man Technologies's adjusted Free Cash Flow per Share data for the fiscal year that ended in Dec23 was:
Adj_FreeCashFlowPerShare | = | Free Cash Flow per Share | / | CPI of Dec23 (Change) | * | Current CPI (Dec23) |
= | 0.025 | / | 129.4194 | * | 129.4194 | |
= | 0.025 |
Current CPI (Dec23) = 129.4194.
Medicine Man Technologies Annual Data
Free Cash Flow per Share | CPI | Adj_FreeCashFlowPerShare | |
201412 | -0.021 | 99.070 | -0.027 |
201512 | 0.025 | 99.792 | 0.032 |
201612 | -0.074 | 101.863 | -0.094 |
201712 | -0.040 | 104.011 | -0.050 |
201812 | -0.044 | 105.998 | -0.054 |
201912 | -0.230 | 108.420 | -0.275 |
202012 | -0.256 | 109.897 | -0.301 |
202112 | 0.027 | 117.630 | 0.030 |
202212 | -0.136 | 125.222 | -0.141 |
202312 | 0.025 | 129.419 | 0.025 |
Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Medicine Man Technologies (OTCPK:SHWZ) Cyclically Adjusted Price-to-FCF Explanation
Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.
Thank you for viewing the detailed overview of Medicine Man Technologies's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Christine Jones | officer: Chief Legal Officer | C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA ST., SUITE 201, DENVER CO 80239 |
Forrest Hoffmaster | officer: CFO | C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA ST., SUITE 201, DENVER CO 80239 |
Nirup Krishnamurthy | director, officer: President | 4880 HAVANA STREET, SUITE 201, DENVER CO 80239 |
Kathy P Vrabeck | director | 625 WESTPORT PARKWAY, GRAPEVINE TX 76051 |
Jeff Garwood | director | 55 TABBY CIRCLE, DAUFUSKIE ISLAND SC 29915 |
Pratap Chandra Mukharji | director | 4880 HAVANA STREET, SUITE 201, DENVER CO 80239 |
Salim Husan Wahdan | director | 4880 HAVANA ST., STE. 201, DENVER CO 80239 |
Paul Joseph Montalbano | director | 4880 HAVANA ST., STE. 201, DENVER CO 80239 |
Brad Stewart | director | C/O SEMPER PARATUS ACQUISITION CORP., 767 THIRD AVENUE, 38TH FLOOR, NEW YORK NY 10017 |
Justin Dye | director, 10 percent owner, officer: CEO | C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA STREET, SUITE 201, DENVER CO 80239 |
Jeffrey Alley Cozad | director, 10 percent owner | C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA ST., SUITE 201, DENVER CO 80239 |
Crw Capital Holdings Ii, Llc | 10 percent owner | 4740 W. MOCKINGBIRD LANE, STE 195579, DALLAS TX 75209 |
Crw Capital, Llc | 10 percent owner | 4740 W. MOCKINGBIRD LANE, P.O. BOX 195579, DALLAS TX 75209 |
Crw Capital Cann Holdings, Llc | 10 percent owner | 4740 W. MOCKINGBIRD LANE, P.O. BOX 195579, DALLAS TX 75209 |
Brian Ruden | 10 percent owner | C/O 4880 HAVANA STREET, SUITE 102, DENVER CO 80239 |
From GuruFocus
By PRNewswire PRNewswire • 01-19-2023
By PRNewswire • 10-30-2023
By PRNewswire PRNewswire • 03-24-2023
By PRNewswire PRNewswire • 06-05-2023
By PRNewswire PRNewswire • 01-03-2023
By PRNewswire PRNewswire • 07-08-2022
By PRNewswire • 07-26-2023
By PRNewswire PRNewswire • 04-25-2023
By PRNewswire PRNewswire • 12-19-2022
By PRNewswire • 10-20-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.